Profilo
Remi A.
Menes worked as a Director of Sales & Marketing at Merck Frosst Canada Ltd.
He then worked as a Commercial Director at Abbott Canada from 2008 to 2010.
He also worked as a Director at Lääketeollisuus ry and as a Chief Commercial Officer at Aegerion Pharmaceuticals, Inc. In 2016 to 2017, he worked as a Global Chief Commercial Officer at Novelion Therapeutics, Inc. Lastly, he worked as a General Manager at AbbVie Oy.
Mr. Menes obtained his undergraduate and MBA degrees from Concordia University.
Precedenti posizioni note di Remi A. Menes
| Società | Posizione | Fine |
|---|---|---|
| NOVELION THERAPEUTICS INC. | Corporate Officer/Principal | 31/08/2017 |
| Abbott Canada | Corporate Officer/Principal | 01/01/2010 |
Merck Frosst Canada Ltd.
 Merck Frosst Canada Ltd. Pharmaceuticals: MajorHealth Technology Merck Frosst Canada Ltd. is a Canadian pharmaceutical company that has been inventing medicines and vaccines for over 130 years. The company is based in Kirkland, Canada. The company's mission is to save and improve lives by bringing forward solutions for some of the world's most challenging diseases. | Vendite & Marketing | - |
| Lääketeollisuus ry | Direttore/Membro del Consiglio | - |
AbbVie Oy
 AbbVie Oy Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., AbbVie Oy is a Finnish company that manufactures and wholesales pharmaceutical products. The company is based in Espoo, Finland. | Corporate Officer/Principal | - |
Formazione di Remi A. Menes
| Concordia University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development and commercialization of therapies for patients with debilitating rare diseases. The company was founded by David I. Scheer, Gerald L. Wisler and William H. Lewis in 2005 and is headquartered in Cambridge, MA. | Health Technology |
Merck Frosst Canada Ltd.
Merck Frosst Canada Ltd. Pharmaceuticals: MajorHealth Technology Merck Frosst Canada Ltd. is a Canadian pharmaceutical company that has been inventing medicines and vaccines for over 130 years. The company is based in Kirkland, Canada. The company's mission is to save and improve lives by bringing forward solutions for some of the world's most challenging diseases. | Health Technology |
| Abbott Canada | |
| Lääketeollisuus ry | |
Novelion Therapeutics, Inc.
 Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelion Therapeutics, Inc. engaged in the development and commercialization of pharmaceuitical products. It focused in providing new standards of care for individuals living with rare diseases. The company was founded on February 3, 1981 and was headquartered in Vancouver, Canada. | Health Technology |
AbbVie Oy
AbbVie Oy Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., AbbVie Oy is a Finnish company that manufactures and wholesales pharmaceutical products. The company is based in Espoo, Finland. | Health Technology |
- Borsa valori
- Insiders
- Remi A. Menes
